Old Web
English
Sign In
Acemap
>
authorDetail
>
David Sahner
David Sahner
Novartis
Immunology
Medicine
Virology
Interleukin 2
Immunodeficiency
3
Papers
126
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)
2006
The Journal of Infectious Diseases
J. Michael Kilby
R. Pat Bucy
Donna Mildvan
Margaret A. Fischl
Jorge Santana-Bagur
Jeffrey L. Lennox
Christopher D. Pilcher
Andrew R. Zolopa
Jody Lawrence
Richard B. Pollard
Raphaelle El-Habib
David Sahner
Lawrence Fox
Evgenia Aga
Ronald J. Bosch
Ronald T. Mitsuyasu
Show All
Source
Cite
Save
Citations (73)
Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s
2003
Hernan Valdez
Ronald T. Mitsuyasu
Alan Landay
Anne Sevin
Ellen S. Chan
John Spritzler
Spyros A. Kalams
Richard B. Pollard
John L. Fahey
Lawrence Fox
Ann Namkung
Scharla Estep
Ronald B. Moss
David Sahner
Michael M. Lederman
Show All
Source
Cite
Save
Citations (4)
Interleukin-2 Increases CD4+ Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s
2003
The Journal of Infectious Diseases
Hernan Valdez
Ronald T. Mitsuyasu
Alan Landay
Anne Sevin
Ellen S. Chan
John Spritzler
Spyros A. Kalams
Richard B. Pollard
John L. Fahey
Lawrence Fox
Ann Namkung
Scharla Estep
Ronald B. Moss
David Sahner
Michael M. Lederman
Show All
Source
Cite
Save
Citations (49)
1